ABM Therapeutics
Company

ABM Therapeutics

Biotechnology Research San Diego, California, United States 7 employees
Employees
7
Contacts
2
Emails
2

ABM Therapeutics Overview

Headquarters
San Diego, California, United States
Website
www.abmtx.com
Industry
Biotechnology Research
Employees
7
Founded
2015
Funding
30.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ABM Therapeutics

ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from melanoma, lung cancer, and breast cancer. It was founded in 2015 by a group of biotech and pharmaceutical industry veterans with more than 20 years of experience in the development of neurological drugs and enterprise management from North America. Since establishment, ABM is building its broad proprietary pipeline internally to construct a brain medicine R&D platform through collaborations with CROs and partners. Our leading program ABM-1310, is highly potent and selective BRAF inhibitor with an excellent cell permeability and brain penetration. The compound was designed to address cancers with BRAFV600 mutation. BRAF mutation happens in about 8% total cancers, such as colorectal cancer, melanoma drug resistance and brain metastasis, and glioma (current drugs are limited by poor brain penetration), as potentially the best-in-class. It was granted the Investigational New Drug (IND) approval in November 2019 in the USA. (Clinical trial information: NCT04190628) More information about ABM’s ongoing ABM-1310 trial is available at www.ClinicalTrials.gov and on the company website at www.abmtx.com. ABM-1310 also got IND approval by NMPA in China in November 2021. ABM-168 is a potent allosteric MEK inhibitor with good cell permeability and BBB penetration. Our approach is to combine ABM-168 with another oncogenic driver inhibitor such as a BRAF inhibitor. The compound received IND approval by FDA in Oct. 2022.

ABM Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

ABM Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Charles Huang
Email
William Liu VP, Head of Clinical Operations
Email
Xian Li 凯泰资本Kaitai Capital - Partner
View
Priscilla (Hueiping) Lee Clinical Operation Associate Director
View

Employees by Management Level

VP / Head 1 profile
Director 1 profile
Individual contributor 1 profile

Compare Similar Companies to ABM Therapeutics